Chief Executive Officer (CEO) and founder
Head of Strategic Innovation and Grants
Chief Operating Officer (COO)
QC and Product Development Manager
Marketing and Sales Manager
QA and Production Manager
Chief Finance Officer (CFO)
Early Stage Researcher/PhD student
HansaBioMed Life Sciences Ltd is a company entirely dedicated to research and development of products in the field of exosome sciences.
Our mission is to develop and commercialize proprietary platforms, kits, reagents and equipment for exosomes research in the Life Science market.
HansaBioMed Life Sciences is a world-wide pioneer in releasing the catalogue featuring the widest choice and selection of products dedicated to exosome research available on the global Life Science market. The portfolio includes lyophilized exosomes from numerous cell lines and body fluids, exosome purification tools, EV binding antibodies and kits for enrichment and quantification of specific exosome subpopulations and of scpecific EV shuttled molecules (proteins, RNAs and DNA). Beside catalogue products HansaBioMed Life Sciences is actively offering custom product and service based projects, extending the capacities and translating EV based approaches to novel and advanced biomedical applications. To this purpose the company collaborates with leading international research groups, both academic and industrial, to further develop and implement technologies and standards in the field.
HBM Research Projects:
HBM-LS will be dedicated to the exploitation, dissemination, and communication of results, training of young scientists and operators in new skills, connecting with the relevant actors in the current international and EU research scenes and paying attention, supported by Lonza, to plan a future EU industrial roadmap beyond the TRL 2-3 that evFOUNDRY will achieve. In particular, within the project, HBM-LS specifies and offers the standards and referent methods and assays for set-up and bench-marking of novel protocols and devices in the projects’s pipeline.
HBM-LS will also test the integrated evFOUNDRY modular-system for its processing performance metrics and implement a lab-scale prototype for a scale-up production of quality-compliant immunomodulatory EVs.
Telephone : (+372)6561996
Operative and legal address Akadeemia tee 15A, 12618 Tallinn, Estonia
CSGI, Department of Chemistry University of Florence,
via della Lastruccia 3, 50019 Florence (Italy)
CSGI, Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy
CSGI, Department of Chemistry University of Florence, via della Lastruccia 3, 50019 Florence (Italy)
evFOUNDRY has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 801367